60 Participants Needed

Light Therapy for Chronic Pain

MC
Overseen ByMatthew C Mauck, MD, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of North Carolina, Chapel Hill
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Participants with chronic pain conditions including chronic low back pain and fibromyalgia may benefit from light stimuli presented to the retina to reduce chronic pain severity and pain sensitivity. Participants will be recruited into this study and will be presented with one of three uniform light stimuli via a wide-field ganzfeld in three conditions to determine the retinal mechanisms that reduce pain. This work will lead to a greater understanding of retinal mechanisms that contribute to pain and will assist the design of future studies to harness the potential of light based pain therapies.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the study team or your doctor.

What data supports the effectiveness of this treatment for chronic pain?

Research shows that green light exposure can reduce pain intensity in conditions like migraines and fibromyalgia, and a study found that visual stimulation can increase pain tolerance. Additionally, a clinical trial demonstrated that green and violet laser therapy significantly decreased pain scores in chronic neck and shoulder pain.12345

Is light therapy safe for humans?

Bright light therapy, used for conditions like seasonal affective disorder, can potentially harm the eyes if the light source emits damaging wavelengths. Safety measures include using lamps without harmful emissions and regular eye check-ups, especially for those with existing eye conditions.678910

How does light therapy for chronic pain differ from other treatments?

Light therapy for chronic pain is unique because it uses specific colors of light, like green light, to reduce pain through the visual system, potentially increasing natural pain-relieving chemicals in the body and reducing inflammation without the side effects of drugs. This non-invasive approach can be used alongside other pain management methods to enhance their effects.1461112

Research Team

MC

Matthew C Mauck, MD PhD

Principal Investigator

University of North Carolina, Chapel Hill

Eligibility Criteria

Adults over 18 with fibromyalgia or chronic low back pain, who rate their pain at least 7/10, can join this trial. They must be willing to use a light therapy device for two hours each morning for five days and be able to read and speak English. People with seizure disorders, severe vision impairments, color blindness, pregnancy, or prisoners cannot participate.

Inclusion Criteria

My average pain level is more than 7 out of 10.
I have been diagnosed with fibromyalgia or chronic low back pain.
I am willing to use a light therapy device for 2 hours daily in the morning.

Exclusion Criteria

Pregnancy
I am mentally capable of understanding and agreeing to the trial.
Prisoner Status
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive light stimuli via a portable battery-operated ganzfeld light stimulation device for 2 hours per day for 5 consecutive days

1 week
5 visits (in-person)

Follow-up

Participants are monitored for changes in pain intensity and activity levels after treatment

1 week

Treatment Details

Interventions

  • Equal Energy White stimulation
  • Green Light stimulation
  • S-cone modulating white light
Trial Overview The study tests if different types of light stimuli (Green Light stimulation, Equal Energy White stimulation, S-cone modulating white light) presented through a portable device can reduce chronic pain severity and sensitivity in patients with conditions like fibromyalgia and lower back pain.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: S-cone modulating white lightExperimental Treatment1 Intervention
The S-cone modulating light stimulus will alternate between two light conditions at 500 lux that will activate the S-cones by about 100x differentially between the two conditions while maintaining the L- an M-cones at constant activation between the two alternating conditions using 427 nm versus 545 nm light. The stimulus will be delivered by a portable battery-operated ganzfeld light stimulation device for 2 hours per day for 5 consecutive days.
Group II: Green light stimulusExperimental Treatment1 Intervention
Green light at 500 lux. Participants will view 545 nm green light delivered via a portable battery-operated ganzfeld light stimulation device for 2 hours per day for 5 consecutive days.
Group III: Equal energy white stimulusExperimental Treatment1 Intervention
Equal energy white light at 500 lux. The International Commission on Illumination (CIE) coordinates of this light are (x=y=0.33), indicating that the stimulus appears uniformly white which means that the activation of each of the three classes of photoreceptors are equivalent, thus silencing any chromatic opponency. The stimulus will be delivered by a portable battery-operated ganzfeld light stimulation device for 2 hours per day for 5 consecutive days.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1,588
Recruited
4,364,000+

Findings from Research

A 66-year-old man with color blindness experienced significant reductions in headache pain intensity after exposure to green light therapy (GLED), indicating its potential as a non-pharmacological pain management method.
The results suggest that GLED may work through non-image-forming retinal cells, while the unchanged frequency of headaches implies that other photoreceptors, like cones, might be involved in reducing headache frequency.
Case Report: Green Light Exposure Relieves Chronic Headache Pain in a Colorblind Patient.Cheng, K., Martin, LF., Calligaro, H., et al.[2022]
In a study of 200 chronic pain patients, the color of the paper used for the Numerical Rating Scale (NRS) questionnaire did not affect overall pain scores, indicating that visual stimulation alone may not influence pain perception.
However, patients on antidepressants and those with depression reported higher pain scores when using the red paper compared to the green paper, suggesting that emotional stimuli can impact pain assessment in these groups.
Visual/emotional stimuli and treatment with antidepressants alter Numerical Rating Scale score in patients with chronic pain.Kanai, A., Matsumoto, S., Hayashi, N., et al.[2017]
In a clinical trial involving 43 participants, low-level laser therapy using green and violet wavelengths significantly reduced chronic musculoskeletal pain, with visual analog pain scores dropping from 71.79 to 34.02 just three minutes after treatment (p < 0.0001).
A remarkable 81.4% of participants experienced a reduction of 30% or more in their pain scores, supporting the efficacy of this therapy and leading to the first FDA clearance for the combined use of these laser wavelengths.
Assessing the Impact of High Photon Energy Wavelengths on the Treatment of Chronic Neck and Shoulder Pain.Sammons, T., Gair, K., Silverman, RG., et al.[2023]

References

Case Report: Green Light Exposure Relieves Chronic Headache Pain in a Colorblind Patient. [2022]
Visual/emotional stimuli and treatment with antidepressants alter Numerical Rating Scale score in patients with chronic pain. [2017]
Assessing the Impact of High Photon Energy Wavelengths on the Treatment of Chronic Neck and Shoulder Pain. [2023]
Mechanisms and Pathways of Pain Photobiomodulation: A Narrative Review. [2023]
The application of eyeglass displays in changing the perception of pain. [2004]
Spectral characteristics of light sources for S-cone stimulation. [2019]
Toward an indoor lighting solution for social jet lag. [2023]
A comparison of the Grass strobe and new LED photic stimulator for paediatric electroretinogram recordings. [2021]
Clinical S-cone ERG recording with a commercial hand-held full-field stimulator. [2019]
Bright light therapy in focus: lamp emission spectra and ocular safety. [2007]
11.United Statespubmed.ncbi.nlm.nih.gov
Green Light Exposure Elicits Anti-inflammation, Endogenous Opioid Release and Dampens Synaptic Potentiation to Relieve Post-surgical Pain. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
Glutamatergic and GABAergic neurons in the vLGN mediate the nociceptive effects of green and red light on neuropathic pain. [2023]